UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038104
Receipt number R000042859
Scientific Title A randomized non-inferiority controlled trial of postoperative analgesic effect of epidural anesthesia and rectus sheath block in laparoscopic surgery
Date of disclosure of the study information 2019/09/26
Last modified on 2022/04/06 09:55:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized non-inferiority controlled trial of postoperative analgesic effect of epidural anesthesia and rectus sheath block in laparoscopic surgery

Acronym

A randomized non-inferiority controlled trial of postoperative analgesic effect of epidural anesthesia and rectus sheath block in laparoscopic surgery

Scientific Title

A randomized non-inferiority controlled trial of postoperative analgesic effect of epidural anesthesia and rectus sheath block in laparoscopic surgery

Scientific Title:Acronym

A randomized non-inferiority controlled trial of postoperative analgesic effect of epidural anesthesia and rectus sheath block in laparoscopic surgery

Region

Japan


Condition

Condition

Patients who received either laparoscopic gastrectomy or laparoscopic colectomy.

Classification by specialty

Gastrointestinal surgery Anesthesiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose is to examine whether a single rectus sheath block is not inferior to continuous epidural anesthesia as postoperative analgesia for patients who have undergone either laparoscopic gastrectomy or laparoscopic colectomy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pain scale (Numerical Rating Scale) when coughing 24 hours after surgery

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

Epidural anesthesia group
Before inducing anesthesia, perform catheter placement at the 9th to 11th thoracic vertebrae levels.
Administer 0.375% ropivacaine epidurally at the start of wound closure.
Patient-controlled epidural analgesia (PCEA) starts at the end of surgery. The drug solution is 0.2% Anapain and 3 mcg / mL fentanyl. Settings: Dosing rate 4 mL / h, bolus administration 2 mL, dosing interval 15 minutes or more, maximum one-time bolus administration 4 times.

Interventions/Control_2

Rectus sheath block group
After the introduction of anesthesia, before the start of surgery. At the umbilical level, 15 mL of 0.375% Anapane is administered under echo guide.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Patients scheduled to undergo laparoscopic gastrectomy or laparoscopic colorectal resection of 6 cm or less where the wound is continuous with the umbilicus in addition to the port hole.
Age: 20 years old and younger than 80 years old at the time of obtaining consent
ASA-PS (American Society of Anesthesiologists physical status): 1-3
Patients who have received sufficient explanation for participation in this study, and who have fully understood and agreed to the document by their own will.

Key exclusion criteria

Antiplatelet / anticoagulant therapy
There is a decrease in platelet count (80,000 <mcL), blood coagulation ability abnormality (aPTT> control value + 10 seconds or PT (%) <50%)
History of spine surgery
There is an allergy to the anesthetic used
Weight less than 40 kg
BMI> 30 kg / m2
Patients whose pain is difficult to evaluate (psycho-neuropathy, dementia, restlessness, etc.)
Use regular painkillers
Liver dysfunction (AST or ALT> 100 IU / L)
Renal dysfunction (eGFR <50 mL / min / 1.73m2)

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Yohei
Middle name
Last name Owada

Organization

University of Tsukuba

Division name

Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery

Zip code

305-8576

Address

2-1-1 Amakubo, Tsukuba, Ibaraki

TEL

029-853-3221

Email

y.owada@md.tsukuba.ac.jp


Public contact

Name of contact person

1st name Yohei
Middle name
Last name Owada

Organization

University of Tsukuba

Division name

Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery

Zip code

305-8575

Address

1-1-1 Tennodai, Tsukuba, Ibaraki

TEL

029-853-3221

Homepage URL


Email

y.owada@md.tsukuba.ac.jp


Sponsor or person

Institute

University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Faculty of Medicine, University of Tsukuba

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tsukuba Clinical Research & Development Organization

Address

2-1-1 Amakubo, Tsukuba, Ibaraki

Tel

029-853-3914

Email

t-credo.adm@un.tsukuba.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 09 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

80

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 09 Month 18 Day

Date of IRB

2019 Year 10 Month 10 Day

Anticipated trial start date

2019 Year 10 Month 01 Day

Last follow-up date

2021 Year 05 Month 16 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 09 Month 26 Day

Last modified on

2022 Year 04 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042859


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name